ECTRIMS 2021 – Late Breaking News Oral Presentations

نویسندگان

چکیده

Introduction: In patients with Multiple Sclerosis (pwMS) disease- modifying therapies (DMTs) are known to affect immune response antigens and possibly SARS-CoV2 vaccine. Therefore, post-vaccination serological assessments needed evaluate the effect of vaccine on SARS-CoV-2 antibody response. Objectives aims: We designed a prospective multicenter cohort study enrolling pwMS who were scheduled for SARSCov- 2 vaccination mRNA vaccines (BNT162b2, Pfizer/ BioNTech, Inc or mRNA-1273, Moderna Tx, Inc) their Methods: A blood collection measure before first dose 4 weeks after second was planned, centralized blinded assessment (electrochemiluminescence immunoassay, ECLIA, Roche Diagnostics). Results: Preliminary data collected 780 (76% BNT162b2 24% mRNA-1273) had pre- 4-week assessments. 87 (11.2%) untreated, 154 (19.7%) ocrelizumab, 25 (3.2%) rituximab, 85 (10.9%) fingolimod, cladribine 404 (51.7%) other DMTs. 677 (86.8%) detectable antibodies. At multivariate analysis, levels ocrelizumab (178-fold decrease, p<0.001), fingolimod (26-fold p<0.001) rituximab (17-fold significantly reduced as compared untreated patients. Vaccination mRNA-1273 resulted in systematically 3.5-fold higher level than (p<0.001). Interpretation: pwMS, anti-CD20 treatment led humoral mRNA-based vaccines. As elicits 3.5-higher BNT162b2, this may be preferentially considered under fingolimod. Combining our those that will produced by studying cellular vaccines, including clinical follow-up, contribute better define most appropriate strategies context DMTs MS. time ECTRIMS presentation full sample (about 2000 subjects) presented.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

ACTRIMS-ECTRIMS MSBoston 2014: Oral Presentations

s Multiple sclerosis Journal 2014; 20: (S1) 3–13 10.1177/1352458514547850 © 2014 SAGE Publications ACTRIMS-ECTRIMS MSBoston 2014

متن کامل

2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014): Oral Presentations

Background: It is well established that TH17 lymphocytes are crucial in the pathogenesis of the chronic autoimmune disease multiple sclerosis (MS). However, the importance of IL-17 in MS is still under debate, and other TH17-associated cytokines are likely more crucial in the initiation and maintenance of neuroinflammation. Objectives: In this study, we addressed the function of IL-26 and its r...

متن کامل

Late-breaking News

It has been quite a while since I’ve written one of these columns. Our production team (whose names may be found on the back of the title page) has grown to include some new members. Most notable of these has been Karl Berry, who has provided technical input, editorial input, as well as having gone out and “beat the bushes” to obtain new and interesting articles. The major problem over the past...

متن کامل

Oral Presentations Oral Presentations

ORAL PRESENTATIONS Discussion: Cross-resistance to different antibacterial agents including quinolones and nalidixic acid, chloramphenicol, trimethoprim and in some cases b-lactam antibiotics is a common phenomenon in Gram-negative bacteria (Gutmann et al., 1995). In this study adaptive resistance in Salmonella enterica and E. coli O157, O55 and K-12 was readily achieved by passage in sublethal...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Multiple Sclerosis Journal

سال: 2021

ISSN: ['1352-4585', '1477-0970']

DOI: https://doi.org/10.1177/13524585211047081